|Bid||163.18 x 1100|
|Ask||163.34 x 800|
|Day's range||158.21 - 167.55|
|52-week range||43.11 - 189.26|
|Beta (5Y monthly)||1.38|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Pfizer CEO sees need for a third vaccine dose as Moderna updates its timeline on third booster shot. Pause on the Johnson & Johnson vaccine remains. Yahoo Finance’s Anjalee Khemlani breaks down the details.
Blood clot concerns lack context, experts say, putting pressure on federal agencies to unpause J&J vaccinations.
Moderna (MRNA) closed the most recent trading day at $159.87, moving -0.1% from the previous trading session.